About the Authors
- Thomas J. Moore
- Institute for Safe Medication Practices, Alexandria, Virginia, United States of America
- Joseph Glenmullen
- Department of Psychiatry-Cambridge Hospital, Harvard Medical School, Cambridge, Massachusetts, United States of America
- Curt D. Furberg
- Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America
Mr. Moore has received consulting fees from litigators in cases involving paroxetine, and was an expert witness in a criminal case involving varenicline. Dr. Glenmullen has been retained as an expert witness in cases involving varenicline and psychiatric drugs including antidepressants, antipsychotics, benzodiazepines, mood stablizers, and ADHD drugs. Dr. Furberg has received consulting fees from litigators in cases involving gabapentin. This does not alter the authors' adherence to the PLoS ONE policies on sharing data and materials.
Conceived and designed the experiments: TJM JG CDF. Performed the experiments: TJM. Analyzed the data: TJM JG CDF. Wrote the paper: TJM JG CDF.